| abstract |
The present invention provides tor compositions and methods for treating SARS Co-V2 infection in a patient in need thereof, in particular, the invention provides pharmaceutical compositions comprising monoclonal antibodies, polyclonal antibodies, anti-ideotype antibodies, or mixtures of such antibodies, directed against SARS Co-V2 antigens. Thus, the pharmaceutical compositions and formulations of the invention may be used to deliver antibody therapeutics to the patient for treatment of SARS Co-V2 infection. |